You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic myeloid leukimea

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Ponatinib in CML Patients in Chronic Phase

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Therapeutic drug monitoring
        • Molecular Response
        • Cagliari, Italy
        • +4 more
        Nov 3, 2023

        Chronic Myeloid Leukemia (CML) Trial in France

        Recruiting
        • Chronic Myeloid Leukemia (CML)
          • Annecy, France
          • +11 more
          Jul 18, 2023

          CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

          Recruiting
          • CML
          • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
          • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
            FUNDALEU
          Jun 29, 2023

          Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

          Active, not recruiting
          • Acute Myeloid Leukemia
          • +9 more
          • Los Angeles, California
          • +5 more
          Jan 27, 2023

          Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

          Recruiting
          • Myelofibrosis
          • +2 more
          • Charlottesville, Virginia
            Danyelle Coley
          Jan 18, 2023

          CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

          Recruiting
          • CML, Chronic Phase
          • CML, Accelerated Phase
          • HS-10382(Part 1: Dose escalation)
          • HS-10382(Part 2: Dose expansion)
          • Wuhan, Hubei, China
            Union Hospital affiliated to Tongji Medical College of Huazhong
          Jan 12, 2023

          Condition Vasoregulation Function Endothelium in CML Getting TKI

          Recruiting
          • Chronic Myeloid Leukaemia
          • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
          • Moscow, Russian Federation
          • +1 more
          Jan 11, 2023

          MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

          Not yet recruiting
          • Myelodysplastic Syndromes
          • +3 more
          • Subcutaneous azacitidine
          • Oral decitabine/cedazuridine
          • Newcastle, New South Wales, Australia
            Calvary Mater Newcastle
          May 29, 2023

          Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

          Not yet recruiting
          • Tyrosine Kinase Inhibitors
          • Chronic Myeloid Leukemia
          • treatment of TKI in CML
          • Poitiers, France
            Chu Poitiers
          Feb 21, 2023

          Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

          Not yet recruiting
          • Myelodysplastic Syndrome
          • +4 more
          • UAE Inhibitor TAK-243
          • (no location specified)
          Oct 20, 2022

          Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

          Recruiting
          • Myeloid Malignancies
          • +3 more
          • Houston, Texas
            M D Anderson Caner Center
          Nov 17, 2022

          Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

          Recruiting
          • Acute Biphenotypic Leukemia
          • +13 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 19, 2023

          Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

          Not yet recruiting
          • Acute Myeloid Leukemia
          • +4 more
            • (no location specified)
            Nov 1, 2023

            Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

            Not yet recruiting
            • Acute Lymphoblastic Leukemia
            • +6 more
            • Miltenyi CliniMACS Prodigy ® system
            • (no location specified)
            Mar 23, 2023

            Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

            Recruiting
            • Chronic Phase Chronic Myelogenous Leukemia
            • +3 more
            • Houston, Texas
              M D Anderson Cancer Center
            Aug 11, 2022

            Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

            Not yet recruiting
            • Chronic Myeloid Leukemia, BCR/ABL-Positive
              • Taipei, Taiwan
                National Taiwan University Hospital
              Jul 24, 2022

              Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

              Recruiting
              • Chronic Myeloid Leukemia, Chronic Phase
              • +3 more
              • Augusta, Georgia
              • +1 more
              Jul 14, 2022

              Landscape and Real-life Treatment Outcomes in Hungary: Analysis

              Completed
              • Chronic Myeloid Leukaemia
              • Budapest, Hungary
                Pfizer
              Dec 15, 2022

              3L+ Therapies Among Chronic Myeloid Leukemia and Those With

              Completed
              • Chronic Myeloid Leukemia
                • East Hanover, New Jersey
                  Novartis Investigative Site
                Nov 11, 2022